Scotland · NHS Scotland MSAN
Rifampicin and Isoniazid (Rifinah®) 300mg/150mg tablets
MSAN(2024)61 · Level 2 · issued 30 Oct 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Sanofi are out of stock of Rifinah® 300mg/150mg tablets. Resupply is expected in mid | Out of stock | — |
| 2. Rifinah® 150mg/100mg tablets remain available but are unable to support any increase in | Available | — |
| 3. Rifampicin 300mg capsules and isoniazid 100mg tablets remain available and can support a full | Available | — |
| 4. Isoniazid 50mg tablets remain available and can support a partial uplift in demand. | Available — partial uplift only | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.